Olezarsen Cuts Triglycerides, Reduces Pancreatitis Risk
NEW ORLEANS — When added to standard lipid-lowering therapy, olezarsen, a drug approved in 2024 for patients with…
New genetic test redefines diagnosis and management of hereditary pancreatitis
A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis. Pancreatitis, inflammation…